November 2010 Briefing - DermatologyLast Updated: December 01, 2010.
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for November 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Celecoxib May Prevent Nonmelanoma Skin Cancers
TUESDAY, Nov. 30 (HealthDay News) -- The cyclooxygenase 2 inhibitor celecoxib appears to be an effective chemopreventive agent for nonmelanoma skin cancers in patients who have extensive actinic damage and are at high risk for the cancers, according to research published online Nov. 29 in the Journal of the National Cancer Institute.
Dermatitis May Not Influence Bone Density in Children
MONDAY, Nov. 29 (HealthDay News) -- There appears to be no correlation between low bone mineral density (BMD) and atopic dermatitis in children, and use of topical corticosteroids in children with atopic dermatitis is not associated with a decrease in BMD, according to a study published in the November issue of the Journal of the American Academy of Dermatology.
Patch-Test Screening for Product Allergy Falls Flat
WEDNESDAY, Nov. 24 (HealthDay News) -- A standard patch-test screening series for diagnosing contact dermatitis allergic reactions to skin care products fails to do so in a substantial number of people, according to research published in the November issue of the Journal of the American Academy of Dermatology.
Ablative CO2 Laser Effective for Asian Skin Rejuvenation
WEDNESDAY, Nov. 24 (HealthDay News) -- Fractional ablative carbon dioxide (CO2) laser resurfacing is minimally to moderately effective in rejuvenating the skin of Asian patients, but causes a higher rate of post-inflammatory hyperpigmentation (PIH) than non-ablative fractional resurfacing (NA FR) laser treatment, according to a clinical report published in the November issue of Lasers in Surgery and Medicine.
Combo Laser Treatment Helps in Leg Telangiectasias
MONDAY, Nov. 22 (HealthDay News) -- A novel treatment for leg telangiectasias using sequential pulses from combined long pulsed dye (LPDL) and Nd:YAG lasers produces good results with minimal side effects, according to a clinical report in the November issue of Lasers in Surgery and Medicine.
Smoking Associated With Common Adult Acne Type
MONDAY, Nov. 22 (HealthDay News) -- The type of acne most common in adult females is comedonal postadolescent acne (CPAA), and it appears to be strongly correlated with smoking cigarettes, according to research published in the November issue of the Journal of the American Academy of Dermatology.
White Areas in Hemangiomas Point to Ulceration
FRIDAY, Nov. 19 (HealthDay News) -- In patients with infantile hemangiomas (IHs), early white discoloration predicts ulceration with high sensitivity, according to research published in the November issue of the Archives of Dermatology.
Skiers' Behavior May Not Align With Ultraviolet Risk
FRIDAY, Nov. 19 (HealthDay News) -- Skiers should continue to use sun protection even on cloudy days due to high ultraviolet radiation (UV), according to research published in the November issue of the Archives of Dermatology.
U.S. Health Insurance Compared to 10 Other Nations
FRIDAY, Nov. 19 (HealthDay News) -- Adults in the United States spend more time and money on health insurance than those in many other developed nations, and ultimately deal with more coverage-related disputes and denials, according to research published online Nov. 18 in Health Affairs.
Fraud in Scientific Literature Appears Intentional
THURSDAY, Nov. 18 (HealthDay News) -- Scientific papers retracted after publication due to fraudulent data represent a calculated, deliberate effort to deceive, according to research published online Nov. 15 in the Journal of Medical Ethics.
Experts Show Lack of Consistency in High-Risk SCC
WEDNESDAY, Nov. 17 (HealthDay News) -- Mohs surgeons show a lack of consistency regarding indications for radiologic nodal staging (RNS) and adjuvant radiation therapy (ART) in high-risk cutaneous squamous cell carcinoma (HRCSCC), suggesting a need for clinical trials, according to research published in the November issue of the Archives of Dermatology.
Patients Treated for Severe Acne Have Higher Suicide Risk
FRIDAY, Nov. 12 (HealthDay News) -- Individuals treated with isotretinoin for severe acne are at an increased risk of attempted suicide up to six months after the end of treatment, though there is already an increased risk in acne patients before treatment, so an additional risk due to treatment cannot be established, according to a study published online Nov. 11 in BMJ.
Physician-Industry Financial Ties Decreased Since 2004
FRIDAY, Nov. 12 (HealthDay News) -- Fewer physicians received drug samples, food and beverages, reimbursement, or payment for professional services in 2009 than in 2004, but a large majority of physicians still report financial relationships with industry, according to research published in the Nov. 8 issue of the Archives of Internal Medicine.